| Name | 1-O-tert-butyl 3-O-ethyl piperazine-1,3-dicarboxylate |
|---|---|
| Synonyms |
1-(tert-butyloxycarbonyl)-3-ethoxycarbonyl-piperazine
1-(tert-butyl) 3-ethyl piperazine-1,3-dicarboxylate 1-tert-butoxycarbonyl-3-ethoxycarbonylpiperazine 1-(1,1-dimethylethyl)-3-ethyl 1,3-piperazinedicarboxylate piperazine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 1-tert-Butoxycarbonylpiperazine-3-carboxylic acid ethyl ester 1,3-Piperazinedicarboxylic acid,1-(1,1-dimethylethyl) 3-ethyl ester ethyl 4-(1,1-dimethylethoxycarbonyl)-2-piperazinecarboxylate |
| Density | 1.128g/cm3 |
|---|---|
| Boiling Point | 384.421ºC at 760 mmHg |
| Molecular Formula | C12H22N2O4 |
| Molecular Weight | 258.31400 |
| Flash Point | 186.292ºC |
| Exact Mass | 258.15800 |
| PSA | 67.87000 |
| LogP | 1.02510 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.484 |
| Storage condition | 2-8°C |
| HS Code | 2933599090 |
|---|
|
~94%
183742-29-2 |
| Literature: Pfizer Inc. Patent: US6297380 B1, 2001 ; |
|
~99%
183742-29-2 |
| Literature: Wyeth Holdings Corporation Patent: EP1144368 B1, 2004 ; Location in patent: Page 51 ; |
|
~%
183742-29-2 |
| Literature: TANABE SEIYAKU CO., LTD. Patent: EP1307455 B1, 2005 ; Location in patent: Page/Page column 33 ; |
|
~%
183742-29-2 |
| Literature: Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239 |
|
~%
183742-29-2 |
| Literature: Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239 |
|
~%
183742-29-2 |
| Literature: Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W. Organic Letters, 2014 , vol. 16, # 4 p. 1236 - 1239 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |